[Event Report & Recommendations] HGPI Special Seminar – HGPI Expert Policy Advocacy Platform “Towards the Establishment of a Value-Based Health Care System” (April 27, 2022)
date : 6/10/2022
Tags: Future of the Health Care System, HGPI Seminar, Innovation and Sustainability
On April 22, 2022, Health and Global Policy Institute (HGPI) has released a new set of policy recommendations, ” Towards the Establishment of a Value-Based Health Care System: An Analysis of Value-Based Pricing.”
These recommendations are being released as a part of HGPI’s recently launched “HGPI Expert Policy Advocacy Platform,” which will facilitate the creation and promotion of policy recommendations by HGPI fellows and others associated with the Institute. Through this platform, policy recommendations developed by HGPI Fellows and others are scrutinized and approved by a review committee within HGPI. Upon their approval, HGPI commits to issuing and advocating for the proposals. It is hoped that this new platform will produce a wide variety of both feasible and creative solutions to today’s pressing health policy issues.
As the first phase of this project, Dr. Ataru Igarashi, an HGPI Fellow, has created a set of policy recommendations entitled, “Towards the Establishment of a Value-Based Health Care System.”
For the HGPI Special Seminar, we hosted Dr. Igarashi explained the contents of the Recommendation “Toward The Value-Based Health Care System,” and participants’ questions and comments were answered as needed in an interactive manner, leading to a lively discussion. The recommendation states that measures to deal with increasing medical costs due to the declining birthrate and aging population as well as the increasing sophistication of medical care are urgent issues, and proposes a drug price system, Value-based pricing (VBP), to evaluate innovative drugs as a specific quantitative and qualitative evaluation method to reflect multifaceted values.
A summary of the recommendations can be found below.
Main points of the new recommendations:
1 Sustainability of Health Care System
- Rising healthcare costs due to the declining birthrate, aging population, and the increasing sophistication of medical care must be addressed urgently.
- The effects of medical services can be divided into two categories: “employment-inducing and production spillover effects” and “benefits gained by patients.” The impact of medical services on patients can give rise to a great number of costs, including loss of productivity and the cost of care. The time has come to redefine what value means in healthcare.
- To this point, the focus of drug price debates has been on revising the drug price system to sustain the insurance system (lowering drug prices). However, drug price related costs account for about 20% of healthcare costs, making it difficult to reduce healthcare costs and improve overall healthcare efficiency through this method alone.
- The current price adjustment system is designed to drastically reduce prices when a drug becomes widely used, which may impede the development of drug innovation out of Japan.
2 Methodology for Value-based drug pricing
- It is recommended that a specific quantitative and qualitative evaluation method be adopted to reflect the multifaceted value of drugs through a VBP framework.
- VBP makes it possible to reflect multiple factors in the price, including safety, efficacy, and health economics.
- Factors that are difficult to quantify, such as the magnitude of unmet need, disease severity, and rarity, can be pseudo-quantified using set criteria.
3 Valuation of concrete drugs
- Current drug prices were compared with currently available data showing the quantifiable range of total costs for various drug. Depending on the drug, there were great differences between these two values.
- For drugs that show significant effectiveness after a short period of treatment, the total cost tends to be much higher than the current price. However, total costs are much lower than current prices for drugs that treat severe diseases with low impact on survival.
- Although there is high unmet medical need for drugs such as anticancer drugs, since the value of these drug is not reflected in their prices, there is a risk that access to such drugs will be limited in the future.
- VBP, which evaluates both quantitative and qualitative value, is useful as a system to reflect values that cannot be directly quantified in final drug prices.
For details, please see the PDF below.
*A recommendation written in English is published on June 10, 2022.
(Webinar) HGPI Special Seminar “Towards the Establishment of a Value-Based Health Care System”
[Overview]
■ Date & Time: Wednesday, April 27, 2022; 16:30-18:00 JST
■ Format: Zoom Webinar
■ Host: Health and Global Policy Institute (HGPI)
■ Speaker:
Dr. Ataru Igarashi (Fellow, HGPI/ Associate Professor, Yokohama City University School of Medicine, Unit of Public Health and Preventive Medicine/ Visiting Associate Professor, Graduate School of Pharmaceutical Sciences, The University of Tokyo)
■ Languages: Japanese
■ Participation fee: Free
[Speaker Profile]
Dr. Ataru Igarashi (HGPI Fellow/ Associate Professor, Yokohama City University School of Medicine, Unit of Public health and Preventive Medicine/ Visiting Associate Professor, Graduate School of Pharmaceutical Sciences, The University of Tokyo)
Ataru IGARASHI, Ph.D., is an associate professor at Yokohama City University School of Medicine, Unit of Public Health and Preventive Medicine. In 2002, he graduated from the Faculty of Pharmaceutical Sciences, The University of Tokyo. He started his career at The University of Tokyo as an assistant professor, just after he received his Ph.D. degree in 2008. His areas of expertise are health economics and pharmacoeconomics. His research on vaccination policy, anti-smoking policy and pharmacoeconomics have been used in the governmental decision making process.
日本語
Top Research & Recommendations Posts
- [Announcement] A Turning Point Towards Building Green Healthcare Systems (June 5, 2024)
- [Policy Recommendations] Developing a National Health and Climate Strategy for Japan (June 26, 2024)
- [Publication Report] Guidance on Patient and Public Involvement (PPI) in Health Policymaking: Necessary Initiatives and Good Examples from the Public and Government (March 31, 2024)
- [Policy Recommendations] Obesity Control Promotion Project 2023 “The Next Steps for Engaging and Cooperating with Patients, Citizens, and Communities for Implements of Obesity Control Measurements” (April 8, 2024)
- [Research Report] Healthcare DX Project Research Report of Interviews ”Expectations for the Coming Era of Healthcare DX from People Living with Health Concerns” (June 10, 2024)
- [Policy Recommendations] Recommendation for the Basic Policy on Economic and Fiscal Management and Reform 2024 (June 11, 2024)
- [Policy Recommendations] Kidney Disease Control Promotion Project 2023 “Establishing Kidney Disease Control Measures with Patient, Citizen, and Community Engagement and Collaboration” Policy Recommendations, a Collection of Good Practices of Chronic Kidney Disease (CKD) and Control Measures in Local Governments (February 14, 2024)
- [Research Report] Building a Mental Health Program for Children and Measuring its Effectiveness (June 16, 2022)
- [Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
- [Research Report] The 2023 Public Opinion Survey on Satisfaction in Healthcare in Japan and Healthcare Applications of Generative AI (January 11, 2024)
Featured Posts
-
2024-06-21
[Event Report] HGPI Special Seminar – HGPI Celebrates its 20th Anniversary: Reflecting on HGPI’s Journey from the Past to the Future (January 16, 2024)
-
2024-06-25
[Public Comment Submission] Web based consultations on NCDs and mental health by World Health Organization (June 25, 2024)
-
2024-06-26
[Event Report] Global Expert Meeting “Innovation in Cancer Care in Developing Countries ~City Cancer Challenge Initiatives“ (June 20, 2024)
-
2024-06-26
[Registration Open] (Webinar) The 127th HGPI Seminar: Current Issues and Future Prospects in Establishing a Health System and Protecting Public Health Through Policy (July 18, 2024)
-
2024-07-01
[Registration Open] Meaningful Involvement Promotion Project Online Expert Meeting “Shaping the Future of Health Policy with People with Lived Experience and Citizens” (July 26, 2024)